Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Characterization of the drug supply in Argentina].
Boni S, Marin GH, Tarragona S, Limeres M, Garay V. Boni S, et al. Among authors: tarragona s. Medicina (B Aires). 2023;83(4):522-532. Medicina (B Aires). 2023. PMID: 37582126 Free article. Spanish.
Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
Rearte A, Castelli JM, Rearte R, Fuentes N, Pennini V, Pesce M, Barbeira PB, Iummato LE, Laurora M, Bartolomeu ML, Galligani G, Del Valle Juarez M, Giovacchini CM, Santoro A, Esperatti M, Tarragona S, Vizzotti C. Rearte A, et al. Among authors: tarragona s. Lancet. 2022 Mar 26;399(10331):1254-1264. doi: 10.1016/S0140-6736(22)00011-3. Epub 2022 Mar 15. Lancet. 2022. PMID: 35303473 Free PMC article.
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.
Rodriguez AE, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Rodriguez Granillo AM, Rodriguez-Granillo GA, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios IF, Serruys PW; ORAR III Investigators. Rodriguez AE, et al. Among authors: tarragona s. EuroIntervention. 2009 Jun;5(2):255-64. doi: 10.4244/eijv5i2a40. EuroIntervention. 2009. PMID: 20449934 Clinical Trial.
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial).
Rodriguez AE, Palacios I, Rodriguez-Granillo AM, Mieres JR, Tarragona S, Fernandez-Pereira C, Solorzano L, Pauletto R, Serruys PW, Antoniucci D; ORAR-3 investigators. Rodriguez AE, et al. Among authors: tarragona s. Am J Cardiol. 2014 Mar 1;113(5):815-21. doi: 10.1016/j.amjcard.2013.11.033. Epub 2013 Dec 13. Am J Cardiol. 2014. PMID: 24528614 Clinical Trial.